Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.61 |
| ▸ | PRKCG | P05129 | 2/20 | 0.61 |
| ▸ | PRKCB | P05771 | 2/20 | 0.61 |
| ▸ | PRKCA | P17252 | 2/20 | 0.61 |
| ▸ | PRKCH | P24723 | 2/20 | 0.61 |
| ▸ | PRKCI | P41743 | 2/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.61 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.61 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 13/20 | 0.55 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1681846 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL16638072 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL9873267 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL21518914 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL16912929 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25268261 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22960177 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL21518916 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22960173 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3785512 | 1.00 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100179151-A1 | TRANSDERMAL APPLICATION OF TRIAZINES FOR CONTROLLING INFECTIONS WITH COCCIDIA | BAYER ANIMAL HEALTH GMBH (DE) | 2010-07-15 | — | — | US | disclosed |
| US-7652071-B2 | Penetration of active substances into cells and organs | ALPHA-BIOCARE GMBH (DE) | 2010-01-26 | — | — | US | disclosed |
| US-7652071-B2 | Penetration of active substances into cells and organs | ALPHA-BIOCARE GMBH (DE) | 2010-01-26 | — | — | US | disclosed |
| CN-101505756-A | Transdermal administration of triazines to control coccidial infections | BAYER ANIMAL HEALTH GMBH (DE) | 2009-08-12 | — | — | CN | disclosed |
| EP-2054064-A2 | TRANSDERMAL APPLICATION OF TRIAZINES FOR CONTROLLING COCCIDIA INFECTIONS | Bayer Animal Health GmbH (DE) | 2009-05-06 | — | — | EP | disclosed |
| EP-1613354-B1 | USE OF CYCLIC ACETALS/ CETALS FOR IMPROVED PENETRATION OF ACTIVE SUBSTANCES INTO CELLS AND ORGANS | BAYER HEALTHCARE AG (DE) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008019785-A2 | TRANSDERMAL APPLICATION OF TRIAZINES FOR CONTROLLING COCCIDIA INFECTIONS | BAYER ANIMAL HEALTH GMBH (DE) | 2008-02-21 | — | — | WO | disclosed |
| US-20070270503-A1 | Penetration of Active Substances Into Cells and Organs | BAYER HEALTHCARE AG (DE) | 2007-11-22 | — | — | US | disclosed |
| US-20070270503-A1 | Penetration of Active Substances Into Cells and Organs | BAYER HEALTHCARE AG (DE) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179151-A1 | TRANSDERMAL APPLICATION OF TRIAZINES FOR CONTROLLING INFECTIONS WITH COCCIDIA | TTL, IL5, DPM1 | PRKD3 3865/4885PRKCG 3628/4885PRKCB 3744/4885 |
| US-20070270503-A1 | Penetration of Active Substances Into Cells and Organs | SLC2A1, SLC2A2, SLC2A3 | PRKD3 2782/4885PRKCG 2184/4885PRKCB 2227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.